Emily Dillard, PA
Physician Assistant · Birmingham, ALNPI 1164121919
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.9% of the total across 410 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 31 manufacturers, the largest accounting for just 21.1% — the pattern of someone who eats at a lot of different presentations. Among physician assistant clinicians in AL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 410 payments — averaging $21.43 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- QOL Medical, LLC$872
- Sanofi$804
- Ardelyx, Inc.$753
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$545
- Johnson & Johnson$471
- plus $3K from 25 others
What the payments were for
- Food & beverage$8,68699%
- Education$1001%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 67 | $1,850 |
| QOL Medical, LLC | 40 | $872 |
| Sanofi | 32 | $804 |
| Ardelyx, Inc. | 37 | $753 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 30 | $545 |
| Johnson & Johnson | 19 | $471 |
| Takeda Pharmaceuticals U.S.A., Inc. | 32 | $456 |
| Regeneron Healthcare Solutions, Inc. | 18 | $399 |
| Lilly USA, LLC | 17 | $312 |
| Pfizer | 16 | $299 |
| Gilead | 10 | $275 |
| Aimmune Therapeutics, Inc. | 16 | $262 |
| Madrigal Pharmaceuticals | 10 | $207 |
| Intercept Pharmaceuticals, Inc. | 10 | $166 |
| E.r. Squibb & Sons, L.L.C. | 2 | $163 |
| Bristol Myers Squibb | 9 | $154 |
| Celltrion USA Inc. | 11 | $138 |
| Axonics, Inc. | 2 | $130 |
| Phathom Pharmaceuticals, Inc. | 10 | $123 |
| Evoke Pharma, Inc. | 5 | $95 |
| Ipsen Biopharmaceuticals, Inc | 3 | $72 |
| Fresenius Kabi USA, LLC | 3 | $50 |
| Merck | 2 | $32 |
| Organon | 2 | $27 |
| Novo Nordisk | 1 | $26 |
| Boehringer Ingelheim | 1 | $20 |
| Braintree Laboratories, Inc. | 1 | $20 |
| Ironwood Pharmaceuticals, Inc | 1 | $19 |
| Amgen | 1 | $17 |
| Nestle Healthcare Nutrition Inc. | 1 | $14 |
| Medtronic | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$8,786 in reported general payments places this provider in the 95th percentile of 846 physician assistant providers in Alabama.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| CreonLipase/Protease/Amylase | 49 | $108,559 |
| LinzessLinaclotide | 88 | $56,972 |
| Mesalamine | 19 | $14,261 |
| TrulancePlecanatide | 12 | $11,101 |
| Lubiprostone | 32 | $4,126 |
| Esomeprazole Magnesium | 58 | $3,947 |
| Colestipol Hcl | 53 | $3,792 |
| Pantoprazole Sodium | 363 | $3,790 |
| Dicyclomine Hcl | 157 | $3,472 |
| SutabSod Sulf/Pot Chloride/Mag Sulf | 20 | $3,256 |
| Ursodiol | 31 | $3,149 |
| Balsalazide Disodium | 27 | $2,984 |
| Sucralfate | 118 | $2,875 |
| Cholestyramine LightCholestyramine | 15 | $2,666 |
| Budesonide DrBudesonide | 15 | $2,270 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieCreon, Linzess | $1,850 | $165,531137 claims |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLCTrulance, Plenvu | $545 | $13,23628 claims |
| Braintree Laboratories, Inc.Sutab | $20 | $3,25620 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 846 physician assistant providers in Alabama.
Other physician assistant in Birmingham
- Natalie GeorgeBirmingham$540K
- Valerie GoodwinBirmingham$21K
- Mary TemplinBirmingham$19K
- Marena WindleBirmingham$14K
- Carolyn SmallwoodBirmingham$9K
- Victoria CarterBirmingham$8K
- Amber JacksonBirmingham$7K
- Lauren MillerAnniston$487K
- Brianna BarryEnterprise$29K
- Ashley PeaceMobile$27K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.